SCHEMBL453717

SCHEMBL453717

OCc1ccc(Cl)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL11276850 0.82 NAPRT (0.56)
SCHEMBL28906689 0.82
SCHEMBL28516487 0.82
SCHEMBL305319 0.82 ALDH1A1 (0.49)
SCHEMBL29852296 0.82 ALDH1A1 (0.49)
SCHEMBL7999163 0.79 ALDH1A1 (0.46)
SCHEMBL17799 0.78
SCHEMBL17201196 0.78
SCHEMBL3085028 0.77 GAA (0.55)
SCHEMBL12975502 0.77 NAPRT (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 776 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115851090-A Antibacterial water-based paint spraying coating and processing technology thereof 厦门市金宝源实业有限公司 2023-03-28 CN claimed
CN-110612119-A Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents 西雅图儿童医院(DBA西雅图儿童研究所) 2019-12-24 CN claimed
WO-2018148224-A1 PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) 2018-08-16 WO claimed
US-8907096-B2 N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase HIGH POINT PHARMACEUTICALS, LLC (US) 2014-12-09 US claimed
US-20140315905-A1 N-ADAMANTYL BENZAMIDES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE VTV THERAPEUTICS LLC 2014-10-23 US claimed
US-8809540-B2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase HIGH POINT PHARMACEUTICALS, LLC (US) 2014-08-19 US claimed
US-20130231341-A1 N-ADAMANTYL BENZAMIDES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE HIGH POINT PHARMACEUTICALS, LLC (US) 2013-09-05 US claimed
US-8383820-B2 N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase HIGH POINT PHARMACEUTICALS, LLC (US) 2013-02-26 US claimed
JP-2011524881-A 2011-09-08 JP claimed
EP-2307385-A1 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES Novartis AG (CH) 2011-04-13 EP claimed
US-7919627-B2 Synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine derivatives by protecting the hydroxyl group of (6-chloro-pyridin-3-yl)-methanol, reacting with pyrazole, and reacting with hydroxylamine or a derivative or an oxime ENANTA PHARMACEUTICALS, INC. (US) 2011-04-05 US claimed
US-20100121052-A1 Novel compounds for treating proliferative diseases JAIN RAMA 2010-05-13 US claimed
WO-2009153313-A1 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2009-12-23 WO claimed
US-20080242865-A1 PROCESSES FOR THE PREPARATION OF HYDROXYLAMINES TANG DATONG 2008-10-02 US claimed
WO-2006119417-A1 PROCESSES FOR THE PREPARATION OF O-(6-PYRAZOL-1-YL-PYRIDIN-3-YLMETHYL)-HYDROXYLAMINE ENANTA PHARMACEUTICALS, INC. (US) 2006-11-09 WO claimed
US-20060247440-A1 Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine ENANTA PHARMACEUTICALS, INC. 2006-11-02 US claimed
JP-6315390-A None JP disclosed
JP-9056376-A None JP disclosed
US-4332944-A Compositions and use ZOECON CORPORATION (US) 1982-06-01 US disclosed
JP-H00956376-A 0001-01-01 JP disclosed